Back
Citius Oncology, Inc. Stock Price Chart
Bitcoin was First. NatGold is the Masterpiece.
Reserve Your Tokens Now
Sell
8
CTOR
Citius Oncology, Inc.
Last Price:
$1.11
Seasonality Move:
-8%
7 Day Trial
ALL ACCESS PASS
$
7
Before There's a Price, There's a Position: NatGold Pre-Market
Secure your position now-before access is controlled by price.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTOR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Citius Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Sell |
| 20-day SMA: | 1.1 | Sell |
| 50-day SMA: | 1.15 | Sell |
| 200-day SMA: | 1.59 | Sell |
| 8-day EMA: | 0.57 | Buy |
| 20-day EMA: | 0.28 | Buy |
| 50-day EMA: | 0.12 | Buy |
| 200-day EMA: | 0.03 | Buy |
Citius Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 45.91 | Sell |
| Chaikin Money Flow: | 63060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.14) | Sell |
| Bollinger Bands (100): | (1.11 - 1.77) | Sell |
Citius Oncology, Inc. Technical Analysis
| Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Oncology, Inc. Stock
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.08 while CTOR 8-day simple moving average is 1.10, which is a Sell signal.
-
The stock price of CTOR is 1.08 while Citius Oncology, Inc. 20-day SMA is 1.10, which makes it a Sell.
-
Citius Oncology, Inc. 50-day simple moving average is 1.15 while CTOR share price is 1.08, making it a Sell technically.
-
CTOR stock price is 1.08 and Citius Oncology, Inc. 200-day simple moving average is 1.59, creating a Sell signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
8
Citius Oncology, Inc. (CTOR)
is a Sell
Is Citius Oncology, Inc. a Buy or a Sell?
-
Citius Oncology, Inc. stock is rated a SellThe current Citius Oncology, Inc. [CTOR] share price is $1.08. The Score for CTOR is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology, Inc. Stock Info
Market Cap:
91.6M
Price in USD:
1.08
Share Volume:
94.9K
Citius Oncology, Inc. 52-Week Range
52-Week High:
6.19
52-Week Low:
0.55
Sell
8
Citius Oncology, Inc. (CTOR)
is a Sell
Citius Oncology, Inc. Share Price Forecast
-
What is the Citius Oncology, Inc. stock price today?The Citius Oncology, Inc. stock price is 1.08 USD today.
-
Will CTOR stock go up or go down?Citius Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology, Inc. is overvalued.
Is Citius Oncology, Inc. Stock a Buy?
-
Citius Oncology, Inc. share price is 1.08 while CTOR 8-day exponential moving average is 0.57, which is a Buy signal.
-
The stock price of CTOR is 1.08 while Citius Oncology, Inc. 20-day EMA is 0.28, which makes it a Buy.
-
Citius Oncology, Inc. 50-day exponential moving average is 0.12 while CTOR share price is 1.08, making it a Buy technically.
-
CTOR stock price is 1.08 and Citius Oncology, Inc. 200-day simple moving average is 0.03, creating a Buy signal.
Technical Analysis of Citius Oncology, Inc.
Should I short Citius Oncology, Inc. stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Citius Oncology, Inc. is a Buy
-
Citius Oncology, Inc. Relative Strength Index (RSI) is 45.91, which suggest Citius Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Citius Oncology, Inc. is (1.06 - 1.14), which suggest Citius Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Oncology, Inc. is (1.11 - 1.77), which suggest Citius Oncology, Inc. is a Sell
* Citius Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.